ABSTRACT Alzheimer's disease (AD) is characterized by amyloid‐β (Aβ) peptide accumulation and tau protein‐mediated neurodegeneration, and neuroinflammation is increasingly recognized as a major process associated with tau pathology. Chronic Toxoplasma gondii infection reduces amyloid accumulation in AD models through immune modulation, but its stage ...
Seung‐Hwan Seo +3 more
wiley +1 more source
Modification of early behavioural, physiological and neuropathological endpoints by syntaxin-6 knockout in a humanised P301S transgenic model of tauopathy. [PDF]
Hill E +16 more
europepmc +1 more source
Clinicopathological features of primary tauopathies: a brain bank series. [PDF]
Ryan B +5 more
europepmc +1 more source
An Integrative Proteomic Approach to Reveal Altered Signaling Modules During Alzheimer's Disease Progression in PS19 Tauopathy Mice. [PDF]
Cho E +7 more
europepmc +1 more source
Mass spectrometry-based proteomic profiling of human tauopathy brains suggests mitochondria-associated alterations. [PDF]
Jannah AR +14 more
europepmc +1 more source
Muscle &Nerve, Volume 74, Issue 2, Page 496-499, August 2026.
Hiroyasu Inoue +7 more
wiley +1 more source
Florzolotau (18F) retention is linked to neuropsychological performance in tauopathy. [PDF]
Shimizu A +24 more
europepmc +1 more source
Brainstem pathology in anti-IgLON5 disease: new insights into early events and tau progression. [PDF]
Reinecke R +28 more
europepmc +1 more source
Clinicoanatomic localization of iron-rich gliosis in aphasic presentations of globular glial tauopathy. [PDF]
Irwin DJ +19 more
europepmc +1 more source
A critical appraisal of the link between apolipoprotein E and Tau. [PDF]
Das S, Hyman BT, Serrano-Pozo A.
europepmc +1 more source

